| Application no. and date | 99301412.5 (espacenet) (Federated) (European Patent Register), 19990225 | | Patent/reg. no. and date | DK/EP 0943331, 20010627 | | Publication date | 19990922 | | Priority no. and date | GB 9804013, 19980225 | | EP pub. no. and date |
EP 0943331 19990922 | | Effective date | | | Applicant/owner | Sanofi-Synthélabo, 174, Avenue de France
75013 Paris, FR,
SANOFI-SYNTHELABO, 174, Avenue de France
75013 Paris, FR | | Applicant ref. no. | 30994 DK 01 | | Inventor | Anderson, Nicholas H., 7 The Dell
Morpeth,
Northumberland NE61 3JY, GB,
Blundell, Ross, 85 Roseberry Crescent
Jesmond,
Newcastle upon Tyne NE2 1EX, GB,
Brown, Stephen, 32 Victoria Avenue
Saffron Walden,
Essex CB11 3AE, GB,
England, David A., 16 Emily Davison Avenue
Morpeth,
Northumberland NE61 2PL, GB,
Gray, Martin R., 29 Allerburn Lea
Alnwick,
Northumberland NE66 2NJ, GB | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | A61K 47/12, A61K 9/08, A61K 31/28 | | Title | Formuleringer indeholdende oxaliplatin | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | Udløbet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
